| BSE: 530125 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE103E01016 |
| BSE 00:00 | 20 Jul | 126.70 |
3.45 (2.80%) |
OPEN
118.60 |
HIGH
126.90 |
LOW
118.60 |
| NSE 05:30 | 01 Jan | Samrat Pharmachem Ltd |
| OPEN | 118.60 |
| PREVIOUS CLOSE | 123.25 |
| VOLUME | 560 |
| 52-Week high | 170.40 |
| 52-Week low | 49.00 |
| P/E | 12.17 |
| Mkt Cap.(Rs cr) | 39 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Samrat Pharmachem Ltd is planning to de-merge its Second Unit in favour of newly formed company viz. Samrat Remedies Ltd w.e.f. April 1, 2004....> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Lalit Mehta | ||||||
| Executive Director : | Rajesh Mehta | ||||||
| Independent Director : | Mahendra Pipalia | ||||||
| Independent Director : | Samir Kothary | ||||||
| Independent Director : | Renu Dharod | ||||||
| Executive Director : | Megh Mehta | ||||||
| AUDITOR : | Shah & Savla LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Plot No A2/3445, GIDC Phase IV,Ankleshwar,Gujarat-393002 | |||||||
| Ph : 91-2646-220774 | |||||||
| WEBSITE : http://www.samratpharmachem.com | |||||||
| E-mail : samrat@bom4.vsnl.net.in | |||||||
